Studies on the mechanism of action of caroxazone, a new antidepressant drug.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D000928:Antidepressive Agents; D044482:Benzeneacetamides; D001921:Brain / Q000201:enzymology; D006719:Homovanillic Acid / Q000378:metabolism; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D008297:Male; D008928:Mitochondria / Q000201:enzymology; D008995:Monoamine Oxidase / Q000378:metabolism; D010078:Oxazines / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D014191:Tranylcypromine / Q000494:pharmacology
D000928:Antidepressive Agents; D044482:Benzeneacetamides; D010078:Oxazines; D015102:3,4-Dihydroxyphenylacetic Acid; D014191:Tranylcypromine; D006897:Hydroxyindoleacetic Acid; C006919:caroxazone; D008995:Monoamine Oxidase; D006719:Homovanillic Acid